*BTI* From Conception to Clinical Trial: Examples of Technology Development

Timeslot: Thursday, April 12, 2018 - 1:45pm to 3:45pm
Track: Career and Commercialization
Room: Grand Ballroom B

About

The session seeks to illustrate the entire development cycle of biomaterials-based technologies from conception to the clinic. The aim is to give the audience perspective on the development process through specific examples with supporting data. Presenters from industry and academia/healthcare settings are welcome. Talks may be of extended duration (20 mins) and could be presented by a single speaker or two speakers (a scientist/engineer and a clinician to separately present the pre-clinical and clinical outcomes).

Abstracts

  • 1:45 p.m. 213. Invited Speaker: Jeff Karp, PhD, Brigham and Women's Hospital, Harvard Medical School

  • 2:15 p.m. 214. Invited Speaker: David Kaplan, PhD, Tufts University

  • 2:45 p.m. 215. Development of a Sprayable Biopolymer Hydrogel for the Prevention of Postoperative Adhesions, L Costella*(1), M Patterson(1), B Janet(1), P Cottler(2), C Tison(1); (1)Luna Innovations, Charlottesville, VA, (2)University of Virginia, Charlottesville, VA

  • 3:00 p.m. 216. Translation of a Crosslinked Hyaluronic Acid Gel for Corneal Repair from the Bench to Veterinary and Human Medicine, B. Mann*(1), S. Atzet(2), B. Wirostko(1); (1)EyeGate Pharmaceuticals, Salt Lake City, UT, (2)SentrX Animal Care, Salt Lake City, UT

  • 3:15 p.m. 217. 3D bioprinting personalized neural tissues for drug screening applications, M. Robinson(1), L. Abelseth(1), S. Singh(1), C. Blood(1), S. Wadsworth*(2), S. Willerth(1); (1)University of Victoria, Victoria, BC, (2)Aspect Biosystems, Vancouver, BC

  • 3:30 p.m. 218. High throughput solution deposited hydroxyapatite coatings for orthopedic implants, C. Ernsberger, S. Vass, B. Smith, J. Langhorn, H. Qu, D. Ettensohn, R. Kasinath*; DePuy Synthes Joint Reconstruction, Warsaw, IN